A model of treatment decision making when patients have advanced cancer: how do cancer treatment doctors and nurses contribute to the process?

被引:24
作者
McCullough, L. [1 ]
McKinlay, E. [2 ]
Barthow, C. [3 ]
Moss, C. [3 ]
Wise, D. [4 ]
机构
[1] Wellington Hosp, Capital & Coast Dist Hlth Board, Wellington 6242, New Zealand
[2] Univ Otago, Sch Med & Hlth Sci, Wellington, New Zealand
[3] Victoria Univ Wellington, Grad Sch Nursing Midwifery & Hlth, Wellington, New Zealand
[4] C Community Hlth, Hutt Valley DHB, Lower Hutt, New Zealand
关键词
disciplinary involvement; doctors; nurses; roles; advanced cancer; treatment decision making; PALLIATIVE CHEMOTHERAPY; CARE; ONCOLOGY; INFORMATION; MANAGEMENT; LIFE; END; COMMUNICATION; EXPERIENCES; IMPACT;
D O I
10.1111/j.1365-2354.2009.01074.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This qualitative study describes how doctors and nurses report their contribution to treatment decision-making processes when patients have advanced cancer. Thirteen nurses and eight doctors involved in cancer treatment and palliation in one geographical location in New Zealand participated in the study. Data were collected using qualitative in-depth, face-to-face interviews. Content analysis revealed a complex context of decision making influenced by doctors and nurses as well as the patient and other factors. A model of clinician and patient decision making emerged with a distinct and cyclical process as advanced cancer remits and progresses. When patients have advanced cancer, nurses and doctors describe a predictable model of decision making in which they both contribute and that cycles through short- and long-term remissions; often nowadays to the point of the patient dying. In conclusion, the findings suggest doctors and nurses have different but complementary roles in what, when and how treatment choices are negotiated with patients, nevertheless within a distinct model of decision making.
引用
收藏
页码:482 / 491
页数:10
相关论文
共 50 条
[1]   Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial [J].
Aranda, S. ;
Schofield, P. ;
Weih, L. ;
Milne, D. ;
Yates, P. ;
Faulkner, R. .
BRITISH JOURNAL OF CANCER, 2006, 95 (06) :667-673
[2]  
Archer V R, 1999, Oncologist, V4, P470
[3]   Interacting with cancer patients: the significance of physicians' communication behavior [J].
Arora, NK .
SOCIAL SCIENCE & MEDICINE, 2003, 57 (05) :791-806
[4]   Who wants second-line, palliative chemotherapy? [J].
Balmer, CE ;
Thomas, P ;
Osborne, RJ .
PSYCHO-ONCOLOGY, 2001, 10 (05) :410-418
[5]  
BEECH W, 2003, J PSYCHOSOC ONCOL, V1, P1
[6]   The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy [J].
Booth, Sara ;
Moosavi, Shakeeb H. ;
Higginson, Irene J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (02) :90-100
[7]   Facilitating day-to-day decision making in palliative care [J].
Bottorff, JL ;
Steele, R ;
Davies, B ;
Porterfield, P ;
Garossino, C ;
Shaw, M .
CANCER NURSING, 2000, 23 (02) :141-150
[8]   Chemotherapy for cancer patients who present late [J].
Bowcock, SJ ;
Shee, CD ;
Rassam, SMB ;
Harper, PG .
BRITISH MEDICAL JOURNAL, 2004, 328 (7453) :1430-1432
[9]   Defining limits in care of terminally ill patients [J].
Braun, Ursula ;
Beyth, Rebecca J. ;
Ford, Marvella E. ;
McCullough, Laurence B. .
BRITISH MEDICAL JOURNAL, 2007, 334 (7587) :239-241
[10]   Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer? [J].
Brown, P ;
Clark, MM ;
Atherton, P ;
Huschka, M ;
Sloan, JA ;
Gamble, G ;
Girardi, J ;
Frost, MH ;
Piderman, K ;
Rummans, TA .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (01) :52-58